WHO says vaccine safety top priority, as AstraZeneca pauses study

Due to concerns over side effects


Reuters September 09, 2020
PHOTO: REUTERS/FILE

ZURICH:

Safety of a prospective vaccine for COVID-19 comes “first and foremost”, the World Health Organization’s chief scientist said on Wednesday, as a trial of a candidate from AstraZeneca was paused, at least temporarily, due to concerns over side effects.

“Just because we talk about speed...it doesn’t mean we start compromising or cutting corners on what would normally be assessed,” Dr. Soumya Swaminathan said on a social media event. “The process still has to follow through rules of the game. For drugs and vaccines which are given to people, you have to test their safety, first and foremost.”

WHO officials did not immediately respond directly to questions from Reuters over the move by AstraZeneca to pause global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness in a study participant.

COMMENTS (1)

keyslog | 4 years ago | Reply

The safety of a future Covid-19 vaccine comes "first and foremost", the chief scientist of the World Health Organization said on Wednesday, as a trial of a flagship candidate of AstraZeneca was suspended due to concerns about side effects. Deploying an effective vaccine is seen as a crucial step in helping struggling economies recover from the coronavirus pandemic. "Just because we are talking about speed ... doesn't mean that we start to compromise or cut corners on what would normally be valued," Dr Soumya Swaminathan said during an event on social networks. Thank you fro valuable information.

Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ